» Articles » PMID: 21056632

Expression of Nurr1 During Rat Brain and Spinal Cord Development

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2010 Nov 9
PMID 21056632
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Nurr1 is a member of the nuclear receptor superfamily and is a regulatory factor of differentiation, migration and maturation of mesencephalic dopaminergic neurons. The present study was designed to observe the dynamic changes in the protein expression of Nurr1 and the relationship between Nurr1 and proliferating cell nuclear antigen (PCNA) during rat brain and spinal cord development. And we also investigated the significance of Nurr1 in differentiation and migration of nerve cells. Paraffin-embedded sections, immunohistochemistry, immunohistochemical double staining and Western blot techniques were used. The results demonstrate that the presence of Nurr1-positive cells increased during embryo development and that these cells slowly migrated to locations far from the lateral ventricle. In postnatal rats, the presence of Nurr1-positive cells surrounding the lateral ventricle decreased markedly. The expression of Nurr1 in the cerebral cortex peaked at postnatal days 1-5 (P1-P5) and then decreased as the cells matured, becoming rare in the mature cerebral cortex. As the cells matured, a staircase-shaped migration of Nurr1-positive cells from dorsal areas to ventral areas of the spinal cord could be observed. As maturation continued, the presence of Nurr1-positive cells in the spinal cord decreased, and no Nurr1-positive cells were found in the mature spinal cord. The comparative observation of Nurr1 and PCNA showed that the two proteins were expressed in different regions and in different cells. Nurr1 was confined to differentiated and migrating immature cells and was not present in proliferating cells. We suggest that Nurr1 may play a regulatory role in the differentiation, migration and maturation of nerve cells in the rat brain and spinal cord.

Citing Articles

Astragaloside IV Treats Parkinson's Disease by Regulating the Proliferation and Differentiation of NSCs through the SHH-Nurr1 Pathway.

Wu Z, Zhang J, Gao H, Li W Stem Cells Int. 2024; 2024:2792909.

PMID: 39257865 PMC: 11387078. DOI: 10.1155/2024/2792909.


The role of NURR1 in metabolic abnormalities of Parkinson's disease.

Al-Nusaif M, Yang Y, Li S, Cheng C, Le W Mol Neurodegener. 2022; 17(1):46.

PMID: 35761385 PMC: 9235236. DOI: 10.1186/s13024-022-00544-w.


Developmental Patterning and Neurogenetic Gradients of Positive Neurons in the Rat Claustrum and Lateral Cortex.

Fang C, Wang H, Naumann R Front Neuroanat. 2021; 15:786329.

PMID: 34924965 PMC: 8675902. DOI: 10.3389/fnana.2021.786329.


The Pathology of Morphine-Inhibited Nerve Repair and Morphine-Induced Nerve Damage Is Mediated via Endoplasmic Reticulum Stress.

Liu J, Yi S, Shi W, Zhang G, Wang S, Qi Q Front Neurosci. 2021; 15:618190.

PMID: 33679302 PMC: 7935558. DOI: 10.3389/fnins.2021.618190.


Dysregulation of Dopaminergic Regulatory Factors TH, Nurr1, and Pitx3 in the Ventral Tegmental Area Associated with Neuronal Injury Induced by Chronic Morphine Dependence.

Shi W, Zhang Y, Zhao G, Wang S, Zhang G, Ma C Int J Mol Sci. 2019; 20(2).

PMID: 30634592 PMC: 6358784. DOI: 10.3390/ijms20020250.